The regulator HIF1α functions in a cancer-microenvironment that lacks oxygen, and it may be involved in resistance to immune checkpoint blockade therapy.

The UAB Hazelrig-Salter Radiation Oncology Center and the Kirklin Clinic at Acton Road will obtain their ASTRO-APEx accreditation until September 2027.

Even when at odds with his health, Matalon continued his academic excellence and service to the field of lung disease research.

The potential affiliation will help RMC Health System to sustain and improve access to high-quality, low-cost care close to home.

The clinically approved drug ruxolitinib suppressed a mouse model of melanoma that is resistant to immune checkpoint blockers.

Because the beam of photons is so tightly focused, proton therapy has little effect on surrounding healthy tissue, making it especially beneficial for young patients.

Record $95 million Heersink lead gift to advance strategic growth and biomedical innovation.

UAB and Proton International open the first proton therapy center for cancer treatment in Alabama.

This new, non-invasive way to deliver radiation has helped one Alabama man complete optometry school and launch his new career.